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Enteropathy-associated T-cell lymphoma (EATL) is a rare peripheral T-cell lymphoma which was classified into 2
types based on histology. EATL is often, but not always, associated with celiac disease. EATL type I is a large cell
lymphoma which is more common in frequency and highly associated with celiac disease compared with type II.
Jejunum and ileum are the common sites, although EATL can rarely occur in the duodenum, stomach and colon or
outside the gastrointestinal tract. We herein presented one case of gastric EATL, which happened in a 73-year-old
Chinese male patient. Histologically, the tumor was composed of polymorphic (pleomorphic, anaplastic,
immunoblastic) lymphoid cells and numerous inflammatory cells, including histiocytes, neutrophils and eosnophils
in the background. The pleomorphic lymphoid cells were diffuse and strongly positive for CD3 and partially positive
for CD30, while negative for CD4, CD5, CD8 or CD56. The gastric EATL should be distinguished from other gastric
lesions, such as peptic ulcer, poorly-differentiated adenocarcinoma and other types of lymphoma.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/1174320824810970
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Enteropathy-associated T cell lymphoma (EATL) is a
rare primary extranodal T cell lymphoma which was
thought to arise from the intraepithelial cells of the
small intestines [1]. Based on the criteria of World
Health Organization (WHO), EATL was divided into
two subtypes. EATL type I is usually associated with re-
fractory celiac disease and covers 80-90% of all EATL
cases. This type frequently has large-cell or pleomorphic
cytology and seldom expresses CD8 and CD56. EATL
type II is sporadic, seldom associated with celiac disease,
and covers 10-20% of all EATL cases and is character-
ized by monomorphic cytology with frequent expression
of CD8 and CD56 [2]. Although EATL seldom occurs in
stomach, it should be considered in the differential diag-
nosis when the lesion exhibits neoplastic lymphoid cells* Correspondence: wangeh775@gmail.com
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reproduction in any medium, provided the orwith infiltration background. In some cases, these in-
flammatory cells may be so abundant as to obscure the
relative small number of tumor cells creating great diag-
nostic confusion with peptic ulcer. Considering the
morphology of EATL, it should also be distinguished
with other gastric tumors and lesions, such as peptic
ulcer, poorly-differentiated adenocarcinoma and other
types of lymphoma (especially diffuse large B-cell lymph-
oma and anaplastic large cell lymphoma).Case presentation
Clinical History
A 73-year-old man presented with epigastric and hu-
meral back intermittent colic pain, nausea, and epigas-
tric fullness of 2 months’ duration. Physical examination
showed tenderness in upper central abdomen just below
the xiphoid process. Hematological and chemical studies
gave normal results. Conventional ultrasonography
revealed an ulcer (30×50 mm) at the greater curvature
to anterior wall of the stomach. The computed tomog-
raphy scan showed no obvious lesions in the spleen,td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Wang et al. Diagnostic Pathology 2012, 7:172 Page 2 of 6
http://www.diagnosticpathology.org/content/7/1/172pancreas, and kidneys. The patient had no history of re-
fractory celiac disease. The patient underwent biopsy
twice under gastroscope, while the result was not satis-
fied due to too much necrosis. We could not rule out
the possibility of malignancy according to the result of
ultrasonography and computed tomography scan. The
patient desired to undergo surgery on his own initiative,
and subtotal gastrectomy was performed. The patient
was alive with no tumor recurrence or metastasis within
3 months of follow-up.Gross features
Grossly, the resected specimen contained a centrally
ulcerated mass (30×50×20 mm) at the greater curvature
to anterior wall of the stomach. The ulcer was irregularFigure 1 Histological features of this case. A: The tumor formed an ulce
the adjacent gastric mucosa. C and D: The ulcer was deep and caused the
Neoplastic lymphoid cells (black arrow) were scattered amidst the inflamm
also observed (red arrow).in shape, upheaved in edge and covered by the yellow-
tan exudate.
Microscopic features
The tumor formed an ulcerating mucosal mass that
invades the wall of stomach (Figure 1A-F). The ulcer
was deep and caused the transmural infiltration by florid
mixed inflammatory cells which were also seen in the
lamina propria of adjacent non-ulcerated mucosa
(Figure 1A-D). However, careful scrutiny revealed vary-
ing numbers of neoplastic lymphoid cells amidst the in-
flammatory background. The tumor cells exhibited
various cytological appearances with concentrated chro-
matin. The tumor consisted of medium to large pleo-
morphic cells with round or angulated nuclei. Nucleoli
were barely seen. A large number of histiocytes,rating mucosal mass. B: Intraepithelial lymphocytosis was also seen in
transmural infiltration by florid mixed inflammatory cells. E and F:
atory infiltrate. A large number of neutrophils and eosinophils were
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background. In addition, crypt abscesses and atypical
hyperplasia of propria glands were also presented in this
case (Figure 1E-F).
Immunohistochemistry
The immunohistochemical study showed that the pleo-
morphic lymphoid cells were negative for AE1/AE3,Figure 2 Immunohistochemical staining. A: The epithelium of gland wa
staining for CD5, CD8 and CD56. E: The tumor cells were strongly diffuse p
G and H: CD20 and Pax-5 labeled the scattered B cells amidst the inflamm
were positive for CD68. M and N: CD31 and CD34 underlined the rich vasc
index was about 20%. K and L: The intraepithelial lymphocytes in the adjacCD5, CD8, CD56 (Figure 2A-D) and CD4, strongly posi-
tive for CD3 (Figure 2E). The tumor cells were partially
positive for CD30 (Figure 2F). CD20 and Pax-5 labeled
the scattered B cells amidst the inflammatory back-
ground (Figure 2G and H). The histiocytes were labeled
by CD68 (Figure 2I). Ki67 index was about 20%
(Figure 2J). The intraepithelial lymphocytes in the adja-
cent mucosa shared the identical immunophenotypes positive staining for AE1/AE3. B-D: The tumor cells were negative
ositive staining for CD3. F: The tumor cells partially expressed CD30.
atory infiltrate. I: The histiocytes among the inflammatory infiltrate
ular channels, whereas the histiocytoid cells were negative. J: Ki67
ent mucosa were positive for CD3 and CD30.
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addition, the EBER in situ hybridization stain for EBV
was negative. The results were listed in Table 1.
Discussion
EATL is a rare type of peripheral T-cell lymphomas in
gastrointestinal tract and seldom occurs in stomach.
O’Farrelly et al. firstly proposed the term EATL owing
to the close association of this lymphoma with villous at-
rophy of the jejunal mucosa adjacent to EATL in 1986
[3]. EATL accounts for less than 1% of non-Hodgkin’s
lymphoma and was most common in Europe, followed
by North America and Asia [4]. The small intestine is
the most common site of involvement. Presentation in
the duodenum, stomach, colon or outside the gastro-
intestinal tract may occur but is rare [5,6]. Delabie et al.
has reported approximately 8% of the EATL arising in
stomach [7]. In spite of its low prevalence, EATL is one
of the main causes of death in patients with long-lasting
untreated refractory celiac disease, due to its aggressive
nature and unresponsiveness to therapies currently avail-
able. Most of the lymphomas occur in stomach are of B
cell origin [8-10]. Therefore, B cell lymphomas and other
rare T cell lymphomas should be excluded when the
diagnosis of gastric EATL is made. In addition, peptic
ulcer and poorly-differentiated adenocarcinoma should
also be considered in the differential diagnosis.
Although EATL has two subtypes with different histo-
logical features and mimics various gastric neoplasms, it
can still be recognized or suspected on morphologic
grounds. Histologically, the tumor forms an ulcerating
mucosal lesion that invades the wall of gastrointestinal
tract. Most commonly, the tumor cells are relatively
monotonous, medium to large in size, with round or
angulated vesicular nuclei, prominent nucleoli. The cyto-
plasm is moderate to abundant and pale-staining. Less













the EBER in situ hybridization stain for EBV -with numerous inflammatory cells in the background. In
the monomorphic form of EATL type II, the neoplastic
cells have medium-sized round, darkly staining nuclei
with a rim of pale cytoplasm. An inflammatory back-
ground is absent, and necrosis is usually less evident
than in classical EATL type I. Immunohistochemically,
the tumor cells are CD3+, CD4-, CD5-, CD7+, CD8−/+,
CD103+, TCRβ+/−, and contain cytotoxic granule asso-
ciated proteins. In almost all cases, a varying proportion
of tumor cells express CD30. In contrast to EATL type
II, EATL type I seldom expresses CD8 and CD56.
The differential diagnosis includes peptic ulcer, poorly
differentiated adenocarcinoma, B cell lymphomas and
other types of T cell lymphomas that present in the
stomach. In some cases of EATL, the inflammatory cells
may be so abundant as to obscure the relatively small
number of tumor cells and therefore resembles the le-
sion of peptic ulcer. However, the intraepithelial lympho-
cytes of peptic ulcer are polyclonal and typically show
no atypia. The pleomorphic cells in EATL indicate the
property of poorly differentiated adenocarcinoma, but
negative for AE1/AE3 staining will be helpful to distin-
guish between them.
The most common types of lymphomas involving the
stomach are of B cell origin, and include MALT lymph-
oma, diffuse large B cell lymphoma (DLBCL), mantle
cell lymphoma, and occasionally, follicular lymphoma.
Mantle cell lymphoma and follicular lymphoma often
produce multiple polyp-like extensions of the mucosa
(lymphomatoid polyposis), a gross appearance that is not
seen in EATL. DLBCL and Burkitt lymphoma often pro-
duce large masses that may grossly resemble EATL.
Occassionally, the tumor cells of EATL are immunoblast-
like and mimic the cells of DLBCL, but they do not express
B cell markers such as CD20 and Pax-5 which are always
expressed in DLBCL (like other B cell lymphomas). There-
fore, it is readily distinguishable by their immunopheno-
typic characteristics.
Extranodal NK/T cell lymphoma is a lymphoma of
natural killer (NK) or T cell lineage that most commonly
presents with a facial mass. A small percentage of
patients may present with gastrointestinal involvement.
Because the morphology of the tumor cells is so variable,
it is important to consider extranodal NK/T cell lymph-
oma in all cases of aggressive extranodal lymphoma
associated with vascular invasion and necrosis. The key
diagnostic features of NK/T cell lymphoma are the dem-
onstration of NK/T cell markers (CD2, cytoplasmic CD3,
CD56, and cytotoxic granule proteins) and Epstein-Barr
virus (EBV), which is uniformly present. In contrast,
EATL is not associated with EBV infection and infre-
quently expresses CD56.
Gamma-delta T cell lymphoma most commonly
involves the liver and spleen (hepatosplenic gamma-
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other areas in the gastrointestinal tract. The diagnosis of
gamma-delta T cell lymphoma is usually made based
upon biopsy specimens demonstrating infiltrating
atypical lymphocytes that express CD2, surface CD3,
CD7, CD56, and CD16, and do not express CD4, CD5,
CD8 or B-cell surface markers. The atypical lymphocytes
express gamma/delta T cell receptors. Like gamma-delta
T cell lymphoma, EATLs express pan-T antigens (surface
CD3+) and do not express CD4, CD5, or CD8. In con-
trast to gamma-delta T cell lymphoma, EATLs typically
express CD103. The T cell receptor beta gene is clonally
rearranged. In addition, EATL (type I) seldom express
CD56. These properties will be helpful to distinguish
between them.
Patients with anaplastic large cell lymphoma (ALCL)
typically present with painless lymphadenopathy. The
tumor is composed of large blastic cells with horseshoe-
shaped nuclei, prominent nucleoli, with or without a
prominent golgi complex (seen as a paranuclear clearing,
or hof ) in a cohesive growth pattern. By immunohisto-
chemistry, homogeneous and strong expression of CD30
in a membrane/golgi pattern can be observed. There is
also expression of T-cell antigens or no lineage-specific
antigens as in the case of the null cell type. However, a
subpopulation of EATL may resemble ALCL histologi-
cally and partly express CD30. ALCL is not associated
with celiac disease-type symptoms or the presence of the
intraepithelial lymphocytic infiltrates in the adjacent
“normal” mucosa.
In this case, peptic ulcer, poorly differentiated adeno-
carcinoma and B cell lymphoma were easily excluded
because of the monoclonal tumor cells which expressed
only T cell markers. Although tumor cells showed ne-
crosis, positive immunostaining for CD3 and heavy in-
flammatory background, the negative result of EBV
detection and absence of CD56+ NK/T cells excluded
the possibility of extranodal NK/T cell lymphoma and
Gamma-delta T cell lymphoma. ALCL was the most dif-
ficult one to be distinguished among the differential
diagnosis. However, the intraepithelial lymphocytic infil-
tration and partly expression of CD30 were critical to
rule out the diagnosis of ALCL. In addition, the pleo-
morphology and negative staining for CD56 and CD8
led to the diagnosis of EATL type I, but not type II.
Taken these together, our final diagnosis was gastric
EATL type I.
We herein reported a case of EATL arising in stomach
which was an uncommon site for this disease. It worth
noting that the severe necrosis and inflammatory back-
ground, which were also observed in other extranodal T-
lymphomas [5,6,11], may obscure the relatively small
number of tumor cells. For the same reason, the patient
in this study underwent biopsy twice under gastroscope,while the result was not satisfied because of too much
necrosis. In this situation, it was dangerous to make the
diagnosis of gastritis or ulcer without careful evaluation
of the lymphoid component. The final diagnosis in
this case also underlined this point. In addition, as
same as other T-lymphomas occurred in uncommon
sites [12-16], the gastric EATL also exhibits the genetic
disorder which will be helpful to distinguish from react-
ive process.
Conclusion
This case indicates that EATL should be considered in
the differential diagnosis of initial gastric lymphomas to
prevent a wrong diagnosis of other intertia lymphomas.
Thus, a better evaluation of the real frequency of occur-
rence needs to be established for this highly aggressive
malignant tumor in the stomach.
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